Ticker: TSX - TOS
Shares Outstanding: 58,027,389
QUEBEC CITY, May 9 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS) an innovator in sterilization technology for medical
devices in healthcare settings, is pleased to announce the appointment
of Mr. Benoît Deschamps to the position of Chief Financial Officer and
Vice President of Finance, effective June 15, 2011.
"Benoit Deschamps is a senior finance executive with an impressive track
record of accomplishments focused on investment and financing within
large companies and entrepreneurial organizations", said R.M. (Ric)
Rumble, CEO of TSO3. "Benoît joins us at a time when his expertise and guidance will be
most beneficial to TSO3 as we look to grow our business further. We are very pleased to see him
join the Company".
Mr. Deschamps most recently held the position of Executive Vice
President and Chief Financial Officer for Mechtronix World Corporation.
Prior to this, he held positions of Vice President and Treasurer at
Videotron where he played a prominent role in the acquisition of
Videotron by Quebecor, and Vice President, Private Investments at the Caisse de Dépôt et Placement du Québec where he was Vice-President in the Private Investment group and
responsible for private and public corporate debt investments as well
as structured combined debt-and-equity transactions. Mr. Deschamps
holds a M.B.A. in Finance and a Ph.D. in Business Administration
(Finance). He was also an Associate Professor of Finance at both the
HEC, in Montreal and Georgia State University, in Atlanta, where he
taught in areas covering corporate finance at the bachelor, master and
"I look forward to joining an entrepreneurial business such as TSO3, I believe I am joining the Company at an inflection point in its
history and look forward to contributing at both the operational and
strategic levels", commented Benoît Deschamps.
TSO3, founded in Québec City in 1998, specializes in the research and
development of innovative, high-performance medical instrument
sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital
environment and offers an advantageous replacement solutions to other
low temperature sterilization processes currently used in hospitals.
For more information about TSO3, visit the Company's Web site at www.tso3.com
The statements in this release and oral statements made by
representatives of TSO3 relating to matters that are not historical facts (including, without
limitation, those regarding the timing or outcome of any financing
undertaken by TSO3) are forward-looking statements that involve certain risks,
uncertainties and hypotheses, including, but not limited to, general
business and economic conditions, the condition of the financial
markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
The TSX has neither approved nor disapproved the information contained
herein and accepts no responsibility for it.
SOURCE TSO3 INC.
For further information:
Source: TSO3 Inc.
Director, Corporate Communications
(418) 651-0003, Ext. 237